Consequently, further studies to determine whether such non-inclusion α-synuclein aggregate pathology is a general feature of PD patients with mutations in LRRK2 or in Parkin (PRKN), who also frequently present without LBs, are strongly motivated [19]. The gene discussed is PRKN; the disease is Parkinson disease.